Is PBM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PBM. It does not provide personalized investment advice.

PBM (Psyence Biomedical Ltd. Common Shares) Stock Analysis - Financials

Psyence Biomedical Ltd. Common Shares (PBM) is a publicly traded Healthcare sector company. As of October 5, 2026, PBM trades at $5.50 with a market cap of $19.68M and a P/E ratio of 0.00. PBM moved +6.51% today. Year to date, PBM is +3.71%; over the trailing twelve months it is -73.28%. Its 52-week range spans $1.92 to $74.94. Rallies surfaces PBM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are PBM's key financials?

PBM financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PBM recently traded at $5.50. Market cap is $19.68M. P/E ratio is 0.00. Revenue is $0.

PBM Key Metrics

Key financial metrics for PBM
Metric	Value
Price	$5.50
Market Cap	$19.68M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$74.94
52-Week Low	$1.92
Volume	24.20K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

PBM Analyst Consensus

PBM analyst coverage data. Average price target: $0.00.

Common questions about PBM

What are PBM's key financials?: PBM financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PBM recently traded at $5.50. Market cap is $19.68M. P/E ratio is 0.00. Revenue is $0.
Is PBM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PBM. It does not provide personalized investment advice.